Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-23-007334)

Filing Details

Accession Number:: 0000899243-23-007334
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-03-07 16:05:43
Reporting Period:: 2023-03-06

Accepted Time:: 2023-03-07 16:05:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1704292	Zai Lab Ltd	ZLAB	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1835780	Iii Titus Frazor Edmondson	C/O Zai Lab Limited 314 Main Street, 4Th Floor, Suite 100 Cambridge MA 02142	Chief Legal Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
American Depositary Shares	Disposition	2023-03-06	7,965	$40.55	19,400	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. The issuer's ADSs and Ordinary Shares are fully fungible, and this Form 4 reports transactions in terms of ADSs.
The reported transaction was effected pursuant to a sale plan adopted by the Reporting Person, dated 11/14/2022, that expires on 11/30/2023 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.